List view / Grid view
7 October 2015 | By Victoria White
The Cancer Research UK Centres Network Accelerator Award provides infrastructure support to research centres in order to encourage collaboration between different organisations and boost ‘bench to bedside’ science...
7 October 2015 | By Victoria White
C4XD’s most advanced compound, an oral Orexin-1 antagonist for the treatment of addiction, is in formal preclinical safety and toxicity studies...
7 October 2015 | By Victoria White
The Cell History File has been designed to fulfil the role of a ‘cell passport’ that can accompany a tissue or cell derived product as it progresses through various processing stages...
7 October 2015 | By SMi Group
Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November...
7 October 2015 | By Victoria White
Horizon Discovery Group has in-licensed novel kinase inhibitors from Servier that exhibit great promise based on preclinical data for treatment of a range of cancer types...
6 October 2015 | By Victoria White
Cardiff University immunologists have described how an immune system protein - interleukin-27 - regulates the inflammatory process in lymphoid-rich rheumatoid arthritis...
6 October 2015 | By Victoria White
The new building is designed to support the Company’s continuing growth of its research and development operation and is scheduled for delivery in late 2016...
6 October 2015 | By Victoria White
Frost & Sullivan have found that non-therapeutic use of human albumin as an excipient has generated plenty of interest across the industry...
6 October 2015 | By Victoria White
Researchers have found that they can use gene therapy to improve visual in mice models for the vision disorder Leber hereditary optic neuropathy (LHON)...
5 October 2015 | By Victoria White
Initial studies by Oxford University researchers show that targeting the protein, called PAT4, could restrict cancerous cells' ability to grow...
5 October 2015 | By Victoria White
Rats given RGFP966 were more attuned to what they were hearing and were able to retain and remember more information...
5 October 2015 | By Victoria White
The Nobel Prize for Physiology or Medicine has been split this year to recognise work that has revolutionised the treatment of some parasitic diseases...
5 October 2015 | By Victoria White
Biogen will leverage findings from Genomics’ integrated database and analysis tools, which will be used to guide drug research and development...
2 October 2015 | By Victoria White
Elevated levels of TGFb may drive the progression of advanced metastatic cancer. As such, it has become an attractive target for cancer drug development...
2 October 2015 | By Victoria White
The technique allows drugs to last longer in the body and attack both primary cancer tumours and the circulating tumour cells...
